L-Arginine, L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-leucyl-L-histidyl-L-prolyl-L-seryl-L-lysyl-L-valyl-L-alpha-aspartyl-L-leucyl-L-prolyl-
-
L-Arginine, L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-leucyl-L-histidyl-L-prolyl-L-seryl-L-lysyl-L-valyl-L-alpha-aspartyl-L-leucyl-L-prolyl-
structure -
-
CAS No:
1187852-48-7
-
Formula:
C72H116N20O19
-
Chemical Name:
L-Arginine, L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-leucyl-L-histidyl-L-prolyl-L-seryl-L-lysyl-L-valyl-L-alpha-aspartyl-L-leucyl-L-prolyl-
-
Synonyms:
SOR-C13;UNII-C79B5A73C4;C79B5A73C4;CHEMBL4228250;BDBM50459973;DB15366;Q27895873;(4S)-5-(((1S)-2-(((1S)-1-(((1S)-2-((2S)-2-(((1S)-2-(((1S)-5-Amino-1-(((1S)-1-(((1S)-1-(((1S)-1-((2S)-2-(((1S)-1-carboxy-4-guanidino-butyl)carbamoyl)pyrrolidine-1-carbonyl)-3-methyl-butyl)carbamoyl)-3-hydroxy-3-oxo-propyl)carbamoyl)-2-methyl-propyl)ca;1187852-48-7;L-Arginine, L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-leucyl-L-histidyl-L-prolyl-L-seryl-L-lysyl-L-valyl-L-alpha-aspartyl-L-leucyl-L-prolyl-
-
CAS No:
Description
SOR-C13 is under investigation in clinical trial NCT01578564 (Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel).|TRPV6 Calcium Channel Inhibitor SOR-C13 is an inhibitor of transient receptor potential cation channel vanilloid family member 6 (TRPV6, CaT1 or CATL) with potential antineoplastic activity. TRPV6 calcium channel inhibitor SOR-C13 binds to TRPV6 and prevents the influx of calcium ions into TRPV6-expressing tumor cells. This inhibits the activation of nuclear factor of activated T-cell (NFAT) transcription complex which may result in an inhibition of calcium-dependent cancer cell proliferation and an induction of apoptosis in tumor cells overexpressing TRPV6. The TRPV6 ion channel plays a key role in calcium homeostasis and is highly selective for calcium compared to other cations; it is overexpressed in a variety of tumors and initiates tumor cell growth, proliferation and metastases.
L-Arginine, L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-leucyl-L-histidyl-L-prolyl-L-seryl-L-lysyl-L-valyl-L-alpha-aspartyl-L-leucyl-L-prolyl- Basic Attributes
1564.87256155
C79B5A73C4
C101525
Drug Information
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)|A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
SOR-C13
Learn More Other Chemicals
-
L-Arginine, mono(3-methyl-2-oxopentanoate)
72090-04-1
-
L-Arginine, mono(3-methyl-2-oxobutanoate)
72087-41-3
-
L-Arginine, N2-[(1,1-dimethylethoxy)carbonyl]-, hydrochloride (1:1)
35897-34-8
-
L-Arginine, ethyl ester, hydrochloride (1:2) Formula
36589-29-4
-
L-Arginine, [2S-[2α,5α,6β(S*)]]-6-[[amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Formula
59261-05-1
-
L-Arginine, N2-benzoyl-, methyl ester, hydrochloride (1:1) Formula
1784-04-9
-
L-Arginine, conjugate acid (1:1) Structure
17806-42-7
-
L-Arginine, L-alanyl-L-leucyl-L-leucyl-L-leucyl-L-alanyl-L-isoleucyl-L-arginyl-L-lysyl- Structure
258338-15-7
-
What is L-Arginine, N2-acetyl-, ethyl ester, hydrochloride (1:1)
74802-30-5
-
What is L-Arginine, N2-acetyl-, methyl ester, hydrochloride (1:1)
1784-05-0
Request for Quotation